Brain Organoids and Single-Cell Genomics for ASD Pathway Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The phenotypic alterations in the human brain resulting from mutations in autism spectrum disorder (ASD) risk genes are poorly understood, and existing models lack the complexity to accurately replicate human brain development, making it difficult to identify cell type-specific developmental abnormalities and their convergence on shared disease pathology.
Innovation Solution
Reproducible organoid models of the human cerebral cortex, combined with single-cell RNA-seq, single-cell ATAC-seq, proteomics, and electrophysiological analysis, are used to investigate the role of ASD risk genes like SUV420H1, PTEN, ARID1B, and CHD8, revealing cell type-specific neurodevelopmental abnormalities and their molecular mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If human brain development is studied in utero, then the natural developmental process is preserved, but accessibility for study is poor
Solution Approach 1:
Human brain organoids serve as an intermediary model system that recapitulates key aspects of human brain development in vitro. These organoids allow researchers to study neurodevelopmental processes, including the effects of genetic mutations, in a controlled laboratory setting while maintaining the cellular complexity and developmental relevance of human brain tissue.
2Device complexity
If existing brain models are used, then simplicity is maintained, but cellular complexity of human brain development is insufficient
Solution Approach 1:
The patent employs single-cell RNA sequencing and single-cell ATAC sequencing to analyze gene expression and chromatin accessibility at unprecedented resolution. These high-parameter measurements capture the cellular complexity of developing brain organoids, allowing researchers to identify cell type-specific effects of genetic mutations while maintaining manageable data through computational analysis.
3Quantity of substance
If hundreds of ASD risk genes are studied collectively, then genetic coverage is comprehensive, but identification of cell type-specific abnormalities is difficult
Solution Approach 1:
The patent segments the analysis into cell type-specific profiles using single-cell resolution techniques. By clustering cells into distinct types based on gene expression patterns and analyzing each type separately, the study identifies which cell types are specifically affected by mutations in different ASD risk genes, thereby disentangling the complex genetic landscape into interpretable cell type-specific effects.
Solution Approach 2:
The study examines the local quality of gene expression and chromatin accessibility in specific cell types rather than averaging across all cells. This approach reveals that different ASD risk genes affect different cell types in the developing brain, providing nuanced insights into the cellular mechanisms underlying autism spectrum disorders.
Data Source
AI summary
The present disclosure is directed to methods of screening for pathological mechanisms in neurodevelopmental and neuropsychological disorders using brain organoids. The present disclosure is also directed to methods of screening agents using the brain organoids.